Healthy adults
Conditions
Interventions
Ingestion of test food 1 for 8 weeks
Ingestion of test food 2 for 8 weeks
Ingestion of placebo food for 8 weeks
Sponsors
Miura Clinic, Medical Corporation Kanonkai
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Subjects of men and women aged 20 to 49 (2) Subject feeling tired (3) Subjects who do not have allergic symptoms (cedar, cypress) during the test period (4) Subjects who are vulnerable to colds and influenza as a consciousness (5) Subjects who received sufficient explanation about the purpose and content of the test, had the ability to consent, voluntarily volunteered to participate after understanding it well, and agreed to participate in the test in writing.
Exclusion criteria
Exclusion criteria: (1) Subjects with a history of diabetes, liver diseases, renal disease, gastrointestinal disease, cardiac disease, respiratory disease, peripheral vascular disease, or other serious disease. (2) Subjects who have undergone gastrointestinal surgery (3) Subjects with abnormal liver and renal function test values (4) Subjects with diseases currently being treated (5) Subjects using immunosuppressive agents such as steroids (6) Subjects who are allergic to food and drugs (7) Subjects with anemia symptoms (8) Female subjects wishing to become pregnant while participating in this study, pregnant (including those who may be pregnant) or lactating female subjects (9) Subjects who play intense sports and subjects who are on a diet (10)Subjects with extremely irregular eating habits s (11)Subjects who cannot stop taking health foods (including foods for specified health use and foods with functional claims) and quasi-drugs during the test period (12)Subjects who are continuously treated with pharmaceuticals (including OTC and prescription drugs) (13)Subjects who drink more than 40 g of pure alcohol per day for males and 20g of pure alcohol per day for females (14)Subjects with smoking habits (15)Subjects with irregular lives such as shift workers (16)Subjects who are participating in or will participate in other clinical trials at the start of this study (17)Other subjects judged by the investigator or the investigator to be inappropriate for the examination
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Immune cells Activity Cold symptoms score Visual Analogue Scale | — |
Countries
Japan
Contacts
Public ContactMakoto Terashima
Oneness Support Co., Ltd. Clinical Trial Division
Outcome results
None listed